Guidance for surveillance of SARS-CoV-2 variants: Interim guidance, 9 August 2021

SARS-CoV-2 variant data update, England

Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)

Holding gatherings during the COVID-19 pandemic: WHO policy brief

Holding gatherings during the COVID-19 pandemic: WHO policy brief, 2 August 2021

Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)

Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)

Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection

WHO technical consultation on oxygen access scale-up for COVID-19

Safe Eid al Adha practices in the context of COVID-19

COVID-19 Vaccines: safety surveillance manual. Module on safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women

Infection prevention and control during health care when coronavirus disease (‎COVID-19)‎ is suspected or confirmed

Risk assessment for SARS-CoV-2 variant: LAMBDA (VUI-21JUN-01, C.37)

Therapeutics and COVID-19: living guideline

Technical considerations for implementing a risk-based approach to international travel in the context of COVID-19: Interim guidance

Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19

Ethical Framework for WHO’s work in the ACT-Accelerator

Protocol template to be used as template for observational study protocols for sentinel surveillance of adverse events of special interest (AESIs) after vaccination with COVID-19 vaccines.

Implementation guidance for assessments of frontline service readiness: strengthening real-time monitoring of health services in the context of the COVID-19 pandemic

Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities

SARS-CoV-2 variants of concern and variants under investigation in England

Indicator framework for the evaluation of the public health effectiveness of digital proximity tracing solutions

Considerations for quarantine of contacts of COVID-19 cases

Managing family risk: A facilitator’s toolbox for empowering families to manage risks during COVID-19 - Part 2

A family toolbox for managing health and happiness during COVID-19 - Part 1

Hypertension and COVID-19

Management Protocol for Long Haul COVID-19 Syndrome (LHCS)

Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine

Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19

Considerations for implementing and adjusting public health and social measures in the context of COVID-19

Update on WHO Interim recommendations on COVID-19 vaccination of pregnant and lactating women

Young people and COVID-19: Behavioural considerations for promoting safe behaviours

How to manage COVID-19 vaccines without VVM at vaccination service points?

Annexes to the recommendations for use of the Sinovac-CoronaVac vaccine against COVID-19: Grading of evidence, Evidence to recommendation tables

Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines

Use of medical and non-medical/fabric masks for community outreach activities during the COVID-19 pandemic

Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac

Preventing and mitigating COVID-19 at work

WHO COVID-19 infection prevention and control (IPC) pillar achievements.

Programmatic innovations to address challenges in tuberculosis prevention and care during the COVID-19 pandemic

AstraZeneca ChAdOx1-S/nCoV-19 [recombinant], COVID-19 vaccine

Estimating COVID-19 vaccine effectiveness against severe acute respiratory infections (‎SARI)‎ hospitalizations associated with laboratory-confirmed SARS-CoV-2: an evaluation using the test-negative design

COVID-19 Exercise Programme - Drills for Vaccine Deployment

Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief

Expanding our understanding of post COVID-19 condition: report of a WHO webinar

Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222, SII Covishield, SK Bioscience)

Asthma and COVID-19: scientific brief

Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief

Why are there extra doses of vaccine in the vaccine vial?

WHO COVID-19 essential supplies forecasting tool (‎COVID-ESFT)

Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets

WHO COVID-19 infection prevention and control (IPC) pillar achievements. February 2020 – January 2021

Principles for COVID-19 Vaccination in Musculoskeletal and Rheumatology for Clinicians

WHO-convened global study of origins of SARS-CoV-2: China Part

Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine: Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine

How to monitor and report COVID-19 vaccine side effects

Monitoring COVID-19 vaccination: Considerations for the collection and use of vaccination data

Monitoring COVID-19 vaccination: Considerations for the collection and use of vaccination data

WHO Living guideline: Drugs to prevent COVID-19

WHO Living guideline: Drugs to prevent COVID-19

COVID-19 vaccine checklist

COVID-19 vaccine checklist

Health worker communication for COVID-19 vaccination flow diagram

Operational considerations to expedite genomic sequencing component of GISRS surveillance of SARS-CoV-2

Using face masks in the community: first update - Effectiveness in reducing transmission of COVID-19

Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca

Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF)

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Definition and categorization of the timing of mother-to-child transmission of SARS-CoV-2

Data for action: achieving high uptake of COVID-19 vaccines: Interim Guidance

Background document on the mRNA-1273 vaccine (Moderna) against COVID-19

Contact tracing in the context of COVID-19

Protocolos de atención odontológica ante la nueva realidad por COVID-19

Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021

Recomendaciones FACME para la vacunación frente a COVID-19

Las nuevas cepas del SARS-CoV-2, ¿qué se sabe?

Actualización - Estrategia de vacunación frente a COVID-19 en España

COVID-19 Clinical management: living guidance

Online global consultation on contact tracing for COVID-19, 9-11 June 2020

Strategies for Optimizing the Supply of Isolation Gowns

mRNA-1273 vaccine (Moderna) against COVID-19 Background document (draft)

WHO public health research agenda for managing infodemics

Sequencing of SARS-CoV-2 - Version 1

Aide-memoire: Infection prevention and control (IPC) principles and procedures for COVID-19 vaccination activities

Protecting Participants in Bioequivalence Studies for Abbreviated New Drug Applications During the COVID-19 Public Health Emergency

Investigational COVID-19 Convalescent Plasma

Coagulation Systems for Measurement of Viscoelastic Properties: Enforcement Policy During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency

Analysing and using routine data to monitor the effects of COVID-19 on essential health services: practical guide for national and subnational decision-makers

Analysing and using routine data to monitor the effects of COVID-19 on essential health services: practical guide for national and subnational decision-makers

Coronavirus Disease 2019 (COVID-19) Treatment Guidelines

COVID-19: Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins Targeting SARS-CoV-2 Infectivity

Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health

COVID-19 Rapid Response Team Guidance

Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing

How to Make 0.1% Chlorine Solution to Disinfect Surfaces in Healthcare Settings

Product Information as approved by the CHMP on 8 January 2021, pending endorsement by the European Commission

Infection prevention and control guidance for long-term care facilities in the context of COVID-19 update

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 - Version 3.6.0

SARS-CoV-2 genomic sequencing for public health goals: Interim guidance

¿Cómo atender a pacientes con COVID-19?

Providing Care and Treatment for People Living with HIV in Low-Resource Non-US Settings During COVID-19 Pandemic

COVID-19 Vaccine Moderna - Product information

CHMP summary of positive opinion for COVID-19 Vaccine Moderna

Guidance on Providing Pediatric Well-Care During COVID-19

Summary of the Risk Management Plan for COVID-19 Vaccine Moderna

COVID-19 Guidance for Safe Schools

Interim Guidance on Supporting the Emotional and Behavioral Health Needs of Children, Adolescents, and Families During the COVID-19 Pandemic

Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication

Capacitación para personal de salud sobre vacunación contra la COVID-19: Módulos

Cloth Face Coverings

Guidance on the Use of Personal Protective Equipment (PPE) for Pediatric Care in Ambulatory Care Settings During the SARS-CoV-2 Pandemic

COVID-19 Testing Guidance

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19

Information for Pediatric Healthcare Providers

COVID-19 Global Risk Communication and Community Engagement Strategy

Evidence to recommendations: Methods used for assessing health equity and human rights considerations in COVID-19 and aviation

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages

COVID-19 in children and the role of school settings in transmission - Version 1

Comirnaty : EPAR - All authorised presentations

Comirnaty : EPAR - Public assessment report

Commission adopts Recommendation on EU coordinated approach to travel and transport in response to new variant of coronavirus in the UK

COVID-19 vaccination and prioritisation strategies in the EU/EEA

Comirnaty: EPAR - Product Information

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19

CHMP summary of positive apinion for Comirnaty

COVID-19 rapid guideline: managing the long-term effects of COVID-19

Emergency Use Designation of COVID-19 candidate vaccines: Ethical considerations for current and future COVID-19placebo-controlled vaccine trials and trial unblinding

Coronavirus (covid-19): medidas de prevención y control de la infección

Since advice in a crisis

Proposal for a council recommendation on a common framework for the use, validation and mutual recognition of COVID-19 rapid antigen tests in the EU

Emergency Global Supply Chain System (COVID-19) catalogue

Vaccines and Related Biological Products Advisory Committee Meeting

Therapeutics and COVID-19: living guideline - 3rd Version

Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities

COVID-19 rapid guideline: vitamin D

Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities

Risk assessment tool to inform mitigation measures for international travel in the context of COVID-19

Considerations for implementing a risk-based approach to international travel in the context of COVID-19

COVID-19 diagnostic testing in the context of international travel

Evidence to recommendations: COVID-19 mitigation in the aviation sector: Interim guidance - Corrigenda

Mitigating Staff Shortages

Testing Healthcare Personnel

Potential Exposure at Work

Infection Control Guidance

Coronavirus (COVID-19): evidencia relevante para cuidados críticos

Coronavirus disease 2019 (COVID-19) and supply ofsubstances of human origin in the EU/EEA - 2nd update

Checklist to support schools re-opening and preparation for COVID-19 resurgences or similar public health crises

Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine

COVID-19 vaccine introduction and deployment costing tool

Obesity Management and Treatment During COVID-19

Supporting Healthy Nutrition and Physical Activity During the COVID-19 Pandemic

Winter Holidays

Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)

Interim Guidance for Antigen Testing for SARS-CoV-2

COVID-19 Interim Guidance: Return to Sports

Guidance for Dental Settings

Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths

Corrigenda – Maintaining surveillance of influenza and monitoring SARS-CoV-2

Discontinuation of Isolation for Persons with COVID-19 Not in Healthcare Settings

Care for Breastfeeding Women

Feasibility, Potential Value and Limitations of Establishing a Closely Monitored Challenge Model of Experimental COVID-19 Infection and Illness in Healthy Young Adult Volunteers

Public Health Guidance for Potential COVID-19 Exposure Associated with International or Domestic Travel

Guidelines for COVID-19 testing and quarantine of air travellers - Addendum to the Aviation Health Safety Protocol

Breastfeeding Guidance Post Hospital Discharge for Mothers or Infants with Suspected or Confirmed SARS-Co V-2 Infection

Guidance for Health Departments about COVID-19 Testing in the Community

Recommandations pour les repas de Noël

Staying safe from COVID-19 during winter

Mask use in the context of COVID-19

CDC Guidance for Expanded Screening Testing to Reduce Silent Spread of SARS-CoV-2

Know When to Delay your Travel to Avoid Spreading COVID-19

Local restriction tiers: what you need to know

Public Health Guidance for Potential COVID-19 Exposure Associated with International or Domestic Travel

Evidence to recommendations: COVID-19 mitigation in the aviation sector

Rapid hospital readiness checklist: Interim Guidance

Draft landscape of COVID-19 candidate vaccines – 26 November 2020

Know When to Delay your Travel to Avoid Spreading COVID-19

Contact Tracing for COVID-19

Prioritizing Case Investigations and Contact Tracing for COVID-19 in High Burden Jurisdictions

Investigating a COVID-19 Case

Prioritizing COVID-19 Contact Tracing Mathematical Modeling Methods and Findings

Strategies for Optimizing the Supply of N95 Respirators

Prioritizing COVID-19 Contact Tracing Mathematical Modeling Methods and Findings

Polling Locations and Voters

Strategies for Optimizing the Supply of Facemasks

Collection and Submission of Postmortem Specimens from Deceased Persons with Known or Suspected COVID-19

COVID-19 rapid guideline: reducing the risk of venous thromboembolism in over 16s with COVID-19

Therapeutics and COVID-19: living guideline - 2nd Version

Priority medical devices list for the COVID-19 response and associated technical specifications

Preparing for COVID-19 in Nursing Homes

Continuity of essential health services: Facility assessment tool

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19

Operational Considerations for Personal Protective Equipment in the Context of Global Supply Shortages for Coronavirus Disease 2019 (COVID-19) Pandemic: non-US Healthcare Settings

Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK

Cleaning, Disinfection, and Hand Hygiene in Schools – a Toolkit for School Administrators

Maintaining surveillance of influenza and monitoring SARS-CoV-2 – adapting Global Influenza surveillance and Response System (GISRS) and sentinel systems during the COVID-19 pandemic

Interim Operational Considerations for Public Health Management of Healthcare Workers Exposed to or with Suspected or Confirmed COVID-19: non-U.S. Healthcare Settings

The COVID-19 Treatment Guidelines Panel’s Statement on the Emergency Use Authorization of Bamlanivimab for the Treatment of COVID-19

Considerations for Restaurant and Bar Operators

Contact tracing: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases in the European Union – third update

Multisystem Inflammatory Syndrome in Children (MIS-C) Interim Guidance